1. Home
  2. XGN vs HEQ Comparison

XGN vs HEQ Comparison

Compare XGN & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • HEQ
  • Stock Information
  • Founded
  • XGN 2002
  • HEQ 2011
  • Country
  • XGN United States
  • HEQ United States
  • Employees
  • XGN N/A
  • HEQ N/A
  • Industry
  • XGN Medical Specialities
  • HEQ Investment Managers
  • Sector
  • XGN Health Care
  • HEQ Finance
  • Exchange
  • XGN Nasdaq
  • HEQ Nasdaq
  • Market Cap
  • XGN 138.3M
  • HEQ 127.0M
  • IPO Year
  • XGN 2019
  • HEQ N/A
  • Fundamental
  • Price
  • XGN $7.00
  • HEQ $10.56
  • Analyst Decision
  • XGN Strong Buy
  • HEQ
  • Analyst Count
  • XGN 2
  • HEQ 0
  • Target Price
  • XGN $7.50
  • HEQ N/A
  • AVG Volume (30 Days)
  • XGN 237.8K
  • HEQ 43.1K
  • Earning Date
  • XGN 08-04-2025
  • HEQ 01-01-0001
  • Dividend Yield
  • XGN N/A
  • HEQ 9.78%
  • EPS Growth
  • XGN N/A
  • HEQ N/A
  • EPS
  • XGN N/A
  • HEQ N/A
  • Revenue
  • XGN $56,724,000.00
  • HEQ N/A
  • Revenue This Year
  • XGN $19.39
  • HEQ N/A
  • Revenue Next Year
  • XGN $13.27
  • HEQ N/A
  • P/E Ratio
  • XGN N/A
  • HEQ N/A
  • Revenue Growth
  • XGN 1.78
  • HEQ N/A
  • 52 Week Low
  • XGN $1.71
  • HEQ $9.08
  • 52 Week High
  • XGN $7.95
  • HEQ $11.84
  • Technical
  • Relative Strength Index (RSI)
  • XGN 52.23
  • HEQ 51.40
  • Support Level
  • XGN $6.62
  • HEQ $10.45
  • Resistance Level
  • XGN $7.35
  • HEQ $10.56
  • Average True Range (ATR)
  • XGN 0.48
  • HEQ 0.08
  • MACD
  • XGN -0.10
  • HEQ -0.02
  • Stochastic Oscillator
  • XGN 29.63
  • HEQ 38.89

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

Share on Social Networks: